What are the causes of splenomegaly?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Splenomegaly

The most common causes of splenomegaly include liver disease (particularly cirrhosis with portal hypertension), hematologic disorders, infections, and malignancies. A systematic approach to diagnosis is essential for proper management of the underlying condition.

Major Categories of Splenomegaly

Liver Disease and Portal Hypertension

  • Cirrhosis - most common cause of splenomegaly in developed countries 1
  • Portal vein thrombosis - leading to portal hypertension 1
  • Wilson's disease - can present with hepatomegaly and splenomegaly 2
  • Hepatosplenic schistosomiasis - with portal hypertension 2

Infectious Causes

  • Leishmaniasis (Visceral/Kala-azar) - common in endemic regions 2
  • Malaria - particularly with tropical splenomegaly syndrome 2
  • Infectious mononucleosis - common cause in young adults 3
  • Bacterial infections - including typhoid fever, brucellosis, and subacute bacterial endocarditis 2
  • HIV/AIDS - often with opportunistic infections 2

Hematologic Disorders

  • Myeloproliferative disorders - polycythemia vera, essential thrombocythemia, primary myelofibrosis 1
  • Lymphoproliferative disorders - lymphomas, chronic lymphocytic leukemia 2, 1
  • Hemolytic anemias - hereditary spherocytosis, thalassemia 1
  • Primary immune thrombocytopenia (ITP) - may present with mild splenomegaly 2
  • Hemophagocytic lymphohistiocytic syndrome 2

Malignancies

  • Leukemias - acute and chronic forms 2, 1
  • Lymphomas - Hodgkin and non-Hodgkin 1
  • Metastatic cancer - particularly from GI malignancies 4

Autoimmune/Inflammatory Disorders

  • Systemic lupus erythematosus 2
  • Rheumatoid arthritis with Felty syndrome 2
  • Sarcoidosis 4

Other Causes

  • Storage diseases - Gaucher disease, Niemann-Pick disease 4
  • Amyloidosis 4
  • Congestive heart failure - leading to passive congestion 4

Diagnostic Approach

Initial Evaluation

  1. Complete blood count with differential - to identify cytopenias (particularly thrombocytopenia, which is the most common manifestation of hypersplenism) 1
  2. Peripheral blood smear - to detect abnormal cells, parasites, or morphologic changes 2
  3. Liver function tests - including AST, ALT, alkaline phosphatase, bilirubin, and albumin 1
  4. Abdominal ultrasound - first-line imaging modality to confirm splenomegaly and assess for liver disease or portal hypertension 1

Additional Testing Based on Clinical Suspicion

  • Infectious workup - blood cultures, viral studies (EBV, CMV, HIV, hepatitis), malaria smears in endemic areas 2
  • Flow cytometry and bone marrow examination - for suspected hematologic malignancies 2
  • CT or MRI - for detailed assessment of spleen size and focal lesions 1
  • Liver biopsy - when liver disease is suspected 2

Important Clinical Considerations

Complications of Splenomegaly

  • Hypersplenism - sequestration and destruction of blood cells leading to cytopenias 5
  • Splenic rupture - risk increases with size; patients should avoid contact sports 3
  • Increased risk of infections - particularly if functional hyposplenism develops 1

When to Consider Splenectomy

  • Refractory symptoms despite medical therapy
  • Massive splenomegaly causing mechanical symptoms
  • Severe hypersplenism with significant cytopenias
  • Splenic infarction or rupture 1

Key Points to Remember

  • Splenomegaly is almost always a sign of an underlying systemic condition rather than a primary disorder 3
  • Thrombocytopenia is the most common hematologic abnormality associated with splenomegaly 1
  • In tropical regions, infectious causes like malaria and schistosomiasis predominate, while in developed countries, liver disease and malignancy are more common 3
  • Management focuses on treating the underlying cause rather than the splenomegaly itself 3

By systematically evaluating patients with splenomegaly using this approach, clinicians can efficiently identify the underlying cause and initiate appropriate treatment to improve outcomes.

References

Guideline

Hypersplenism Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Splenomegaly: Diagnosis and Management in Adults.

American family physician, 2021

Research

Splenomegaly: Pathophysiological bases and therapeutic options.

The international journal of biochemistry & cell biology, 2018

Research

Splenomegaly, hypersplenism and coagulation abnormalities in liver disease.

Bailliere's best practice & research. Clinical gastroenterology, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.